Abstract: A portable safety ladder assembly having safety extensions to permit safe and easy access to landing areas, working platforms, scaffolds, etc. The safety extension members have a plurality of horizontal handgrips ergonomically designed to prevent falls from the ladder assembly when a user is ascending upward or descending downward thereon.

Abstract: A portable safety ladder assembly having safety extensions to permit safe and easy access to landing areas, working platforms, scaffolds, etc. The safety extension members have a plurality of horizontal handgrips ergonomically designed to prevent falls from the ladder assembly when a user is ascending upward or descending downward thereon.

Abstract: A safety ladder assembly and a safety extension used in combination with a ladder suitable to permit safe and easy access to the landing areas, working platforms, scaffolds, etc. The assembly includes safety extension members having a plurality of horizontal handgrips ergonomically designed to prevent falls from the ladder when a user is ascending upward or descending downward.

Abstract: A safety ladder assembly and a safety extension used in combination with a ladder suitable to permit safe and easy access to the landing areas, working platforms, scaffolds, etc. The assembly includes safety extension members having a plurality of horizontal handgrips ergonomically designed to prevent falls from the ladder when a user is ascending upward or descending downward.

Abstract: This invention relates to compounds having pharmacological activity, to compositions containing these compounds, and to a method of treatment employing the compounds and compositions. More particularly, this invention concerns certain non-imidazole tertiary amine derivatives and their salts and solvates. These compounds have H3 histamine receptor antagonist activity. This invention also relates to pharmaceutical compositions containing these compounds and to a method of treating disorders in which histamine H3 receptor blockade is beneficial.

Abstract: A process for synthesizing L and D-5,5,5,5?,5?,5?-hexafluoroleucine and protected analogs is disclosed. These compounds have utility in the preparation of fluorous peptides and proteins, which display interesting and unusual properties including strong self-association and an affinity for lipid bilayers.

Abstract: A process for synthesizing L and D-5,5,5,5′,5′,5′-hexafluoroleucine and protected analogs is disclosed. These compounds have utility in the preparation of fluorous peptides and proteins, which display interesting and unusual properties including strong self-association and an affinity for lipid bilayers.

Abstract: A process for synthesizing L and D-5,5,5,5′,5′,5′-hexafluoroleucine and protected analogs is disclosed. These compounds have utility in the preparation of fluorous peptides and proteins, which display interesting and unusual properties including strong self-association and an affinity for lipid bilayers.